An evaluation of the bactericidal activity of ampicillin/sulbactam, piperacillin/tazobactam, imipenem or nafcillin alone and in combination with vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) in time-kill curves with infected fibrin clots

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 4, 1997, Pages 515-518

  Palmer, Shirley M ^a,b   Rybak, Michael J ^a  

^a DETROIT RECEIVING HOSPITAL   (United States)

^b Exempla Saint Joseph Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; IMIPENEM; NAFCILLIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULBACTAM; TAZOBACTAM; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; FIBRIN CLOT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

EID: 0030938582     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.4.515     Document Type: Article

References (10)

1. Small, P. M. & Chambers, H. F. (1990). Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrobial Agents and Chemotherapy 34, 1227-31.
2. Levine, D. P., Fromm, B. S. & Reddy, B. R. (1991). Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Annals of Internal Medicine 115, 674-80.
3. Chambers, H. F. & Sachdeva, M. (1990). Binding of β-lactam antibiotics to penicillin-binding proteins in methicillin-resistant Staphylococcus aureus. Journal of Infectious Diseases 161, 1170-6.
4. Cantoni, L., Wenger, A., Glauser, M. P. & Bille, J. (1989). Comparative efficacy of amoxicillin-ciavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats. Journal of Infectious Diseases 159, 989-93.
5. Chambers, H. F. & Sande, M. A. (1992). Ampicillin (A), sulbactam (S), rifampin (R) combination therapy (Rx) of experimental methicillin-resistant Staphylococcus aureus (MRSA) aortic valve endocarditis (AVE) in rabbits. In Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA, 1992. Abstract 1456, p. 353. American Society for Microbiology, Washington, DC.
6. Bayer, A. S. & Li, C. (1993). Ampicillin-sulbactam with rifampin or vancomycin in treatment of experimental endocarditis due to oxacillin-resistant Staphylococcus aureus. In Program and Abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1993, Abstract 152, p. 147. American Society for Microbiology, Washington, DC.
7. Barr, J. G., Smyth, E. T. M. & Hogg, G. M. (1990). In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis. European Journal of Clinical Microbiology & Infectious Diseases 9, 804-9.
8. Cremieux, A. C. & Carbon, C. (1992). Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis. Antimicrobial Agents and Chemotherapy 36, 2069-74.
9. Tomasz, A., Nachman, S. & Leaf, H. (1991). Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci. Antimicrobial Agents and Chemotherapy 35, 124-9.
10. de Lencastre, H., de Jonge, B. L. M., Matthews, P. R. & Tomasz, A. (1994). Molecular aspects of methicillin resistance in Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 33, 7-24.